Why iTeos Therapeutics, Inc. (ITOS) Might be Well Poised for a Surge

Posted byZacks Equity Research Leave a comment on Why iTeos Therapeutics, Inc. (ITOS) Might be Well Poised for a Surge

iTeos Therapeutics, Inc. (ITOS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Leave a comment

Your email address will not be published. Required fields are marked *